Efficacy of Intravenous Racemic Ketamine on Global Severity and Individual Symptoms of Depression
Journal of Clinical Psychopharmacology September 25, 2025 Rachel Landrum, Amanda M. Raines, Philip D. Harvey et al. 1 citation
Maintenance intravenous racemic ketamine therapy demonstrated significant, persistent, and broad efficacy for treatment-resistant depression as demonstrated by reductions in Montgomery-Åsberg Depression Rating Scale and Patient-Health Questionnaire-9 total scores and equivocal changes in every item on both rating scales. The magnitude of change in individual items was similar to that of...